Needham & Company Raises Price Target on NeoPhotonics (NPTN) Following 2Q Results
- Wall Street falls as investors ready for Trump's inauguration
- IBM (IBM) Tops Q4 EPS by 13c, FY17 EPS Guidance Beats Consensus
- American Express (AXP) Misses Q4 EPS by 7c, FY17 EPS Guidance Tops Views at Mid-Poinit
- Skyworks Solutions (SWKS) Tops Q1 EPS by 3c, Offers Q2 Guidance, Announces Buyback
- After-Hours Stock Movers 01/19: (SWKS) (QRVO) (NVAX) Higher; (AFMD) (SGYP) (IBM) Lower (more...)
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Needham & Company reiterated a Strong Buy rating on NeoPhotonics (NYSE: NPTN), and raised the price target to $20.00 (from $18.00), following the company's 2Q earnings report. By CY4Q end, Neo should be producing roughly 75,000 iTLAs per quarter up from 28,000 in CY1Q. Needham increased revenue estimates for CY16 to $421 million.
Analyst Alex Henderson commented, "Neo's CY2Q was a surprise. The reported numbers were just in-line as PONS fell off sharply and Neo moves to end-of-life this lowmargin legacy product line. Conversely, the 100G line was strong - sold-out, and ramping sharply. We are trimming $20 million of PONs Revenues from the model and increasing our overall Revenue forecast on strong 100G and ramping capacity. We view this as good news and a significant improvement in business quality. We are increasing our estimates, raising our Target Price and Reiterating our Strong Buy Rating."
Shares of NeoPhotonics closed at $13.40 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs (GS) PT Raised to $256.00 at Oppenheimer Following 4Q Report
- Netflix (NFLX) PT Raised to $165 at Cowen Amid 'Stellar' Q4
- ADTRAN (ADTN) PT Raised to $27.50 at MKM Partners Following Strong 4Q
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change
Related EntitiesNeedham & Company, Earnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!